Singapore · GxP QA · Global Reach

GxP Excellence.
Integrity in
every step.

Sparsh Strategic Consulting helps pharmaceutical, biotech, and medtech organisations achieve compliance, quality, and regulatory readiness — backed by 25+ years of global experience.

GCP · GMP · GVP · GLP FDA · EMA · MHRA · PMDA Clinical Development Singapore-based
25+
Years of global GxP industry experience
1,000+
GxP audits performed across all major domains
15+
Regulatory bodies including FDA, EMA, PMDA, NMPA, MFDS, TFDA
Sectors served
Pharmaceuticals Biotechnology Medtech & Wearables Contract Research Organisations Site Management Organisations Academic Research Institutions
What we do
Our Services

End-to-end GxP QA consulting, auditing, training, and strategic advisory for life sciences organisations worldwide.

Global GxP Audits & Compliance

Investigator site, pharmacovigilance, CSV, GDP, and for-cause audits with actionable reports and CAPA management.

Regulatory Inspections

Mock inspections, readiness assessments, and post-inspection response for FDA, EMA, MHRA, PMDA, NMPA, MFDS, and TFDA.

GxP Consultancy Services

GCP, GVP, GLP, GMP, CSV, GDP — QMS development, optimisation, and vendor qualification across all GxP areas.

Quality & Risk Management

Risk management across the clinical development cycle, QMS optimisation, and management of serious non-compliance cases.

Training & Education

Customised GCP training, inspection readiness, data integrity programmes, and CAPA implementation workshops.

New Tech & Clinical Development

SaMD, digital health, and wearables quality integration. End-to-end clinical development strategy with holistic patient care perspective.

Who we serve
Industries

Tailored solutions across the life sciences spectrum — from multinational pharma to academic research institutions.

Pharmaceuticals Biotechnology Medtech & Wearables Contract Research Organisations Site Management Organisations Academic Research Institutions
About
Founded on expertise. Built on integrity.

Sparsh Strategic Consulting was founded by Sachin Pasumamula — a GxP quality assurance professional with over 25 years of experience across pharmaceutical, biotech, medtech, and clinical development organisations on five continents.

SP
Sachin Pasumamula
Founder & CEO
LinkedIn

Sachin has conducted and overseen GxP quality assurance engagements across 30+ countries and 5 continents, working directly with health authorities including the FDA, EMA, PMDA, TGA, NMPA, MFDS, and DCGI.

He is the author of Quiet Watchdogs: GxP Quality Assurance — The Unsung Heroes Safeguarding Integrity Across the Drug Development Lifecycle and the founder of SQIP — the Sparsh Quality Intelligence Platform, for which a patent was filed in Singapore in April 2026.

His approach combines deep regulatory knowledge with a genuine belief that quality is not a compliance exercise — it is the foundation of patient safety.

25+
Years of global GxP industry experience
1,000+
Audits performed across all GxP domains
30+
Countries across 5 continents
7
Health authorities — FDA, EMA, PMDA, TGA, NMPA, MFDS, DCGI
Introducing our platform

Meet SQIP — Sparsh Quality Intelligence Platform

Built on 25 years of GxP reasoning expertise, SQIP governs the quality of reasoning behind quality decisions — not as a suggestion, as a constraint. The first platform of its kind.

Patent Filed · Singapore · April 2026 · PCT Pending

Explore SQIP →
Live
SQIP RCA
Live
SQIP Inspect
Live
SQIP CAPA
Building
SQIP Risk
Building
SQIP Oversight
Roadmap
SQIP Memory
Get in touch
Let's talk

Ready to elevate your GxP compliance posture? Drop us a message and a Sparsh principal will respond within 24 hours.